Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04314284 · ClinicalTrials.gov registry record · NA

Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

A NA study of Lung Cancer and Colorectal Cancer, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT04314284 is a NA study of Lung Cancer and Colorectal Cancer that has completed, run by Washington University School of Medicine. The registered enrollment target is 150 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04314284, a NA study of Lung Cancer and Colorectal Cancer, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, and ultimately reduce cancer patients' financial toxicity associated with cancer care.

Interventions

  • BEHAVIORAL I Can PIC
  • OTHER Historical control survey
  • OTHER Post-intervention survey (I Can PIC participants)
  • OTHER Follow-Up survey (I Can PIC participants)

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2020-05-26
Est. Completion 2021-11-04
Phase NA

What the Registry Record Tells You About NCT04314284

The ClinicalTrials.gov registry entry for NCT04314284 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which I Can PIC is the first listed.

NCT04314284 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04314284 about?

NCT04314284 is a clinical study titled "Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity". The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, a...

What is the current status of trial NCT04314284?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-05-26. Estimated completion is 2021-11-04.

What conditions does trial NCT04314284 study?

This clinical trial studies the following conditions: Lung Cancer, Colorectal Cancer, Gynecologic Cancer.

What interventions are being tested in trial NCT04314284?

The interventions under investigation include: I Can PIC (BEHAVIORAL), Historical control survey (OTHER), Post-intervention survey (I Can PIC participants) (OTHER), Follow-Up survey (I Can PIC participants) (OTHER).

Who is sponsoring clinical trial NCT04314284?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04314284 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.